UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

TCR- or Cytokine-Activated CD8+ Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune Responses

Cell reports (Cambridge), 2019-09, Vol.28 (12), p.3061-3076.e5

2019

Volltextzugriff (PDF)

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias

International journal of molecular sciences, 2023-03, Vol.24 (7), p.6406

2023

Volltextzugriff (PDF)

Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells

Scientific reports, 2018-01, Vol.8 (1), p.1-19, Article 1572

2018

Volltextzugriff (PDF)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor

Frontiers in pharmacology, 2022-10, Vol.13, p.1039564-1039564

2022

Volltextzugriff (PDF)

Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite

Forensic toxicology, 2023-01, Vol.41 (1), p.114-125

2023

Volltextzugriff (PDF)

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines

Frontiers in pharmacology, 2018-11, Vol.9, p.1202-1202

2018

Volltextzugriff (PDF)

The evolving small‐molecule fluorescent‐conjugate toolbox for Class A GPCRs

British journal of pharmacology, 2014-03, Vol.171 (5), p.1073-1084

2014

Volltextzugriff (PDF)

Single α-Helical Turn Stabilized by Replacement of an Internal Hydrogen Bond with a Covalent Ethylene Bridge

Angewandte Chemie (International ed.), 2009-01, Vol.48 (31), p.5675-5678

2009

Volltextzugriff (PDF)

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

Trends in pharmacological sciences (Regular ed.), 2022-09, Vol.43 (9), p.754-771

2022

Volltextzugriff (PDF)

Type I interferons are important co‐stimulatory signals during T cell receptor mediated human MAIT cell activation

European journal of immunology, 2020-02, Vol.50 (2), p.178-191

2020

Volltextzugriff (PDF)

Covalent isothiocyanate inhibitors of macrophage migration inhibitory factor as potential colorectal cancer treatments

ChemMedChem, 2024-07, p.e202400394

2024

Volltextzugriff (PDF)

Human liver‐derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR‐independent activation

European journal of immunology, 2021-04, Vol.51 (4), p.879-892

2021

Volltextzugriff (PDF)

Chemical Tools for Studying Lipid-Binding Class A G Protein-Coupled Receptors

Pharmacological reviews, 2017-07, Vol.69 (3), p.316-353

2017

Volltextzugriff (PDF)

To prohibit or regulate psychoactive substances: has New Zealand got the right approach?

BMJ (Online), 2017-03, Vol.356, p.j1195

2017

Volltextzugriff (PDF)

Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor

Chembiochem : a European journal of chemical biology, 2024-07, p.e202400242

2024

Volltextzugriff (PDF)

Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8161-8178

2021

Volltextzugriff (PDF)

Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist

Neuropharmacology, 2015-11, Vol.98, p.68-77

2015

Volltextzugriff (PDF)

Neutrophils suppress mucosal‐associated invariant T cells in humans

European journal of immunology, 2020-05, Vol.50 (5), p.643-655

2020

Volltextzugriff (PDF)

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

ACS medicinal chemistry letters, 2019-02, Vol.10 (2), p.209-214

2019

Volltextzugriff (PDF)

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment

European journal of medicinal chemistry, 2018-02, Vol.145, p.770-789

2018

Volltextzugriff (PDF)

Covalent cannabinoid receptor ligands - structural insight and selectivity challenges

RSC medicinal chemistry, 2022-05, Vol.13 (5), p.497-51

2022

Volltextzugriff (PDF)

Open Synthesis Network Research in an Undergraduate Laboratory: Development of Benzoxazole Amide Derivatives against Leishmania Parasite

Journal of chemical education, 2022-04, Vol.99 (4), p.1682-1690

2022

Volltextzugriff (PDF)

Highly Potent and Selective Fluorescent Antagonists of the Human Adenosine A3 Receptor Based on the 1,2,4-Triazolo[4,3-a]quinoxalin-1-one Scaffold

Journal of medicinal chemistry, 2012-02, Vol.55 (4), p.1771-1782

2012

Volltextzugriff (PDF)

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1 H )-one-3-carboxamide scaffold

MedChemComm, 2018-12, Vol.9 (12), p.2055-2067

2018

Volltextzugriff (PDF)

Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools

RSC advances, 2018-01, Vol.8 (29), p.16362-16369

2018

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(45)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TCR- or Cytokine-Activated CD8+ Mucosal-Associated Invariant T Cells Are Rapid Polyfunctional Effectors That Can Coordinate Immune Responses

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias

Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cells

Editorial: Therapeutic potential of the cannabinoid CB2 receptor

Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines

The evolving small‐molecule fluorescent‐conjugate toolbox for Class A GPCRs

Single α-Helical Turn Stabilized by Replacement of an Internal Hydrogen Bond with a Covalent Ethylene Bridge

Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

Type I interferons are important co‐stimulatory signals during T cell receptor mediated human MAIT cell activation

Covalent isothiocyanate inhibitors of macrophage migration inhibitory factor as potential colorectal cancer treatments

Human liver‐derived MAIT cells differ from blood MAIT cells in their metabolism and response to TCR‐independent activation

Chemical Tools for Studying Lipid-Binding Class A G Protein-Coupled Receptors

To prohibit or regulate psychoactive substances: has New Zealand got the right approach?

Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor

Development of Covalent, Clickable Probes for Adenosine A1 and A3 Receptors

Direct visualisation of internalization of the adenosine A3 receptor and localization with arrestin3 using a fluorescent agonist

Neutrophils suppress mucosal‐associated invariant T cells in humans

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment

Covalent cannabinoid receptor ligands - structural insight and selectivity challenges

Open Synthesis Network Research in an Undergraduate Laboratory: Development of Benzoxazole Amide Derivatives against Leishmania Parasite

Highly Potent and Selective Fluorescent Antagonists of the Human Adenosine A3 Receptor Based on the 1,2,4-Triazolo[4,3-a]quinoxalin-1-one Scaffold

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1 H )-one-3-carboxamide scaffold

Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools

Suchergebnisse filtern